In a filing, Dolby Laboratories Inc revealed its Officer YEAMAN FAMILY TRUST U/A DTD 05 acquired Company’s shares for reported $2.57 million on Jun 10 ’25. In the deal valued at $76.22 per share,33,683 shares were bought.
Then, SHERMAN MARK ANDREW sold 15,000 shares, generating $1,125,286 in total proceeds. Upon selling the shares at $75.02, the EVP, Gen. Counsel & Secretary now owns 62,397 shares.
Before that, MARK ANDREW SHERMAN bought 15,000 shares. Dolby Laboratories Inc shares valued at $1,125,286 were divested by the Officer at a price of $75.02 per share.
A number of analysts have revised their coverage, including Barrington Research’s analysts, who increased its forecast for the stock in early June from “a Mkt perform” to “an Outperform”. Barrington Research also remained covering DLB and has decreased its forecast on November 18, 2022 with a “Mkt perform” recommendation from previously “an Outperform” rating. Rosenblatt started covering the stock on May 24, 2022. It rated DLB as “a Buy”.
Price Performance Review of DLB
On Tuesday, Dolby Laboratories Inc [NYSE:DLB] saw its stock jump 1.31% to $76.49. Over the last five days, the stock has gained 2.04%. Dolby Laboratories Inc shares have fallen nearly -2.06% since the year began. Nevertheless, the stocks have fallen -4.40% over the past one year.
How much short interest is there in Dolby Laboratories Inc?
A steep rise in short interest was recorded in Dolby Laboratories Inc stocks on 2025-05-15, dropping by 10139.0 shares to a total of 1.27 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 1.28 million shares. There was a decline of -0.8%, which implies that there is a negative sentiment for the stock.
